|
|
||||||||
Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ontario N1G 2W1; Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 3Z5; and Department of Clinical Chemistry, Huddinge University Hospital, Karolinska Institute, S-141 86 Huddinge, Sweden
| |
ABSTRACT |
|---|
|
|
|---|
This study
investigated the transformational and posttransformational control of
skeletal muscle glycogen phosphorylase and pyruvate dehydrogenase (PDH)
at three exercise power outputs [35, 65, and 90% of maximal
oxygen uptake
(
O2 max)].
Seven untrained subjects cycled at one power output for 10 min on three
separate occasions, with muscle biopsies at rest and 1 and 10 min of
exercise. Glycogen phosphorylase in the more active
(a) form was not significantly different at any time across power outputs (21.4-29.6%), with the
exception of 90%, where it fell significantly to 15.3% at 10 min. PDH
transformation increased significantly from rest (average 0.53 mmol · kg wet
muscle
1 · min
1)
to 1 min of exercise as a function of power output (1.60 ± 0.26, 2.77 ± 0.29, and 3.33 ± 0.31 mmol · kg wet
muscle
1 · min
1
at 35, 65, and 90%, respectively) with a further significant increase
at 10 min (4.45 ± 0.35) at 90%
O2 max. Muscle
lactate, acetyl-CoA, acetylcarnitine, and free ADP, AMP, and
Pi were unchanged from rest at
35%
O2 max but rose
significantly at 65 and 90%, with accumulations at 90% being
significantly higher than 65%. The results of this study indicate that
glycogen phosphorylase transformation is independent of increasing
power outputs, despite increasing glycogenolytic flux, suggesting that
flux through glycogen phosphorylase is matched to the demand for energy
by posttransformational factors, such as free
Pi and AMP. Conversely, PDH
transformation is directly related to the increasing power output and
the calculated flux through the enzyme. The rise in PDH transformation
is likely due to increased Ca2+
concentration and/or increased pyruvate. These results
demonstrate that metabolic signals related to contraction and the
energy state of the cell are sensitive to the exercise intensity and
coordinate the increase in carbohydrate use with increasing power
output.
glycogenolysis; energy state; carbohydrate; transformation; pyruvate dehydrogenase
| |
INTRODUCTION |
|---|
|
|
|---|
SINCE THE CLASSICAL STUDIES of the 1930s [as
reviewed by Dill (18)], it is has been recognized that a shift
toward greater carbohydrate (CHO) use occurs with increasing aerobic
exercise intensities. Muscle glycogen becomes the primary fuel at
intensities above 50-60% maximal oxygen uptake
(
O2 max; see reviews in
Refs. 10 and 34). Two key enzymes that regulate glycogen use are glycogen phosphorylase and pyruvate dehydrogenase (PDH). Flux through
these enzymes can be controlled by covalent modification [transformation between less active
(b) and more active
(a) forms], allosteric
regulation of the a and
b forms, and changes in the concentrations of substrates and products. Evidence suggests that glycogen phosphorylase, the rate-limiting step in glycogenolysis, is
regulated by a two-stage control system. First,
Ca2+-activated phosphorylation by
phosphorylase kinase causes the initial transformation of glycogen
phosphorylase from the b to a form, setting the potential upper
limit for glycogenolytic flux (5, 15, 17). Posttransformational
regulators linked to the energy state of the cell appear to then
determine the actual flux (7, 8, 30).
PDH catalyzes the decarboxylation of pyruvate to acetyl-CoA for the entry of CHO into the pathways of oxidative metabolism. PDH transformation is controlled by PDH kinase, which phosphorylates and inactivates the complex, and PDH phosphatase, which dephosphorylates and activates the complex (24, 26). The balance between these controlling regulatory enzymes determines the proportion of PDH that will be in the active form. Although glycogen phosphorylase and PDH activities have been studied separately under many conditions, little is known regarding the interrelationship between the two enzymes in controlling glycogen use over a range of exercise intensities. Given that glycogen phosphorylase sets the rate of glycolytic flux at moderate to high power outputs and that PDH is responsible for determining the rate of pyruvate flux into the mitochondria, it seems likely that the activities of the two enzymes are coordinately regulated during aerobic exercise.
During exercise at 35%
O2 max, the majority of
energy is provided by plasma free fatty acid and glucose, with little
or no reliance on muscle glycogen (31). At 65%
O2 max,
muscle glycogenolysis increases, but fat still provides a large
proportion of the required energy. At 90%, the glycogenolytic rate
increases (34), and CHO from glycogen provides the majority of the
required substrate (31). The present study was designed to investigate the transformation state of PDH and glycogen phosphorylase and the
accumulation of several regulators that may influence the transformation state and/or flux through the enzymes at the
following three aerobic power outputs: 35, 65, and 90%
O2 max. Three separate exercise trials were performed to study the transition from rest to
exercise at the desired power output and to eliminate the interactive effects of previous exercise. Our hypotheses were that
posttransformational regulation of glycogen phosphorylase, and not
glycogen phosphorylase transformation, would be important in regulating
glycogenolysis, whereas PDH transformation would be related to the
power output. This coordinated regulation would thus balance the need
for CHO provision and oxidation with increasing power outputs.
| |
METHODS |
|---|
|
|
|---|
Subjects. Seven (3 female, 4 male)
healthy, active subjects volunteered to participate in this study.
Their mean age, weight, and
O2 max were 22.1 ± 0.3 yr, 77.7 ± 3.6 kg, and 47.1 ± 2.3 ml · kg
1 · min
1,
respectively. None of the subjects was well trained, but all participated in some form of regular activity. Subjects were informed of possible risks involved in participation, and informed consent was
received from all subjects. The study was approved by the ethics
committees of both universities.
Preexperimental protocol. Subjects
underwent a continuous incremental exercise test on a bicycle ergometer
to determine
O2 max using a metabolic cart (Quinton Q-Plex 1; Quinton Instruments, Seattle,
WA). From this test, power outputs eliciting 35, 65, and 90% of
O2 max were
calculated. Subjects then reported on two separate occasions to
practice cycling for the required 10 min at these power outputs and to
confirm that the correct percentage of
O2 max was reached.
Mean power outputs for the trials were 58 ± 11, 164 ± 15, and
229 ± 19 W, resulting in percentages of 36.7 ± 1.5, 62.3 ± 1.5, and 90.1 ± 0.6% of
O2 max, respectively.
Experimental protocol. On two separate
experimental days (separated by 2-3 wk), subjects arrived at the
laboratory at the same time of day, having eaten a meal within the
previous 2-3 h. Subjects were asked to consume their normal mixed
diet before the test days. To ensure subjects were in the same
nutritional state for each test day, 48-h dietary records were kept
before their first day and replicated for 48 h before the second day. The average diet composition was 60.0 ± 4.3% CHO, 25.0 ± 2.4% fat, and 15.0 ± 2.0% protein. On one day, subjects cycled for 10 min at the 35% power output, rested for at least 1 h, and cycled for
10 min at the 65% power output, with biopsies taken from separate legs. On the other day, subjects cycled for 10 min at 90%
O2 max. The order of
the two days was randomized. Before each exercise trial, while resting
quietly on a bed, subjects had their legs prepared for needle biopsies
(3), with three incisions made through the skin superficial to the
vastus lateralis muscle under local anesthesia (2% lidocaine without
epinephrine). After a resting biopsy had been taken, subjects moved to
an electronically braked cycle ergometer (Excalibur; Quinton
Instruments) and began pedaling at the prescribed power output.
Exercise biopsies were taken on the cycle ergometer at 1 and 10 min;
samples were immediately frozen in liquid
N2 (3-5 s from the insertion
of the needle), removed from the needle, and stored in liquid
N2. Respired gases were collected
to measure oxygen uptake and carbon dioxide production. At the lower
(35 and 65%) power outputs, gas collection occurred between 4 and 8 min, when subjects were in a metabolic steady state. However, in
anticipation of a significant oxygen uptake (
O2) drift, gas collection
for the 90%
O2 max
trial occurred at 2-4 and 7-9 min of the trial.
Analyses. A small piece of frozen wet muscle (20-30 mg) was removed under liquid N2 for the determination of the PDH transformation state (PDH a), as described by Constantin-Teodosiu et al. (12) and modified by Putman et al. (29). The remainder of the biopsy sample was freeze-dried, dissected of all visible blood, connective tissue, and fat, and powdered for subsequent analysis.
One aliquot (3-4 mg) of freeze-dried muscle was used for determination of the percentage of glycogen phosphorylase in the more active a form (glycogen phosphorylase a) in the exercise biopsy samples (9, 39). The maximal velocity (Vmax) of total (a + b) and a forms and the mole fraction of glycogen phosphorylase in the a form were calculated from the measured activities (5, 7, 9). Glycogen phosphorylase a was not measured for resting time points, because an accurate resting glycogen phosphorylase a value is obtainable only if the biopsy is held from liquid N2 freezing for >30 s (7), requiring a separate biopsy. Resting glycogen phosphorylase a has been measured previously and is ~10% (7, 27).
A second aliquot of freeze-dried muscle was extracted with 0.5 M HClO4 (containing 1 mM EDTA) and neutralized with 2.2 M KHCO3. This extract was used for determination of creatine, phosphocreatine (PCr), ATP, glucose 6-phosphate (G-6-P), lactate, and glucose by enzymatic spectrophotometric assays (2, 22). Acetyl-CoA and acetylcarnitine were determined by radiometric measures (4).
Muscle glycogen was determined on a third aliquot of freeze-dried muscle at rest and 10 min at the 90% power output to quantify the glycogenolytic rate (22).
Calculations. Free ADP and AMP
concentrations were calculated by assuming equilibrium of the creatine
kinase and adenylate kinase reactions as previously described (19).
Free ADP was calculated using the measured ATP, PCr, and creatine
content (19) and a H+
concentration estimated from the muscle lactate content according to
the regression equation of Sahlin et al. (33). Free AMP was calculated
from the ATP concentration and the estimated free ADP. Free
Pi was calculated by adding the
estimated resting free phosphate of 10.8 mmol/kg dry muscle (19) to the
PCr
G-6-P between rest
and each exercise time point. All metabolites and the activities of
glycogen phosphorylase
(Vmax
a and
Vmax total) and
PDH were normalized to the highest total creatine measurement in the
nine biopsies from each subject.
Statistics. All data are presented as
means ± SE. For all dependent variables, a two-way ANOVA (time × power output) with repeated measures was employed. Significance
was set at
= 0.05, and, when obtained, the Tukey post hoc test was
used to identify where significant differences occurred.
| |
RESULTS |
|---|
|
|
|---|
O2 and
respiratory exchange ratio. Exercise
O2 for the 35 and 65% power
outputs was 1.32 ± 0.12 and 2.18 ± 0.19 l/min,
respectively.
O2 at 90% was
2.75 ± 0.26 l/min (2-4 min) and increased to 3.29 ± 0.31 l/min (7-9 min). Respiratory exchange ratios (RER) for the 35 and
65% power outputs were 0.84 ± 0.02 and 0.92 ± 0.02. RER for
the 90%
O2 max trial
was continuously above 1.0 and therefore is not a true representation
of substrate use but indicated substantial use of CHO.
Phosphorylase. Phosphorylase Vmax total was similar between trials at all time points, whereas Vmax a was decreased only at 10 min at 90% (Table 1). The resulting percentage of phosphorylase in the more active a form was unchanged (21.4-29.6%) with both power output and time, with the exception of 10 min at 90%, when glycogen phosphorylase a was lower (15.3%) than at 1 min (Fig. 1).
|
|
PDH a. Resting PDH
activity was similar before all exercise trials (0.40 ± 0.08 to
0.65 ± 0.18 mmol · kg wet
muscle
1 · min
1).
PDH activity increased above rest after 1 min of exercise at all three
power outputs with 65 and 90% being higher than 35% (Fig.
2). PDH at the two lower power outputs did
not subsequently change from 1 to 10 min, whereas at 90% it increased.
|
Muscle metabolites. Muscle glycogen
averaged 360.1 ± 50.1 mmol/kg muscle at rest before the
90%
O2 max trial
and decreased to 235.7 ± 41.3 mmol/kg dry muscle after 10 min
of cycling, resulting in a net utilization of 124.4 ± 14.0 mmol/kg
dry muscle. Glycogen was not determined at the lower power outputs as
the expected change in muscle glycogen in those trials would be below
the detection limits of the assay.
Resting metabolite contents were similar before each trial
(Table 2). During exercise, PCr was
unchanged at 35%
O2 max but was lower at
both 1 and 10 min of exercise at 65 and 90%
O2 max, with 90%
being lower than 65%. Exercise at 90%
O2 max also resulted in
PCr contents that were lower at 10 min than at 1 min. ATP was unchanged
by exercise at all time points and all power outputs (Table 2). Muscle
lactate was unchanged at 35% but increased after 1 and 10 min of
exercise at both 65 and 90%, with 90% being higher than 65% at 10 min (Table 2). G-6-P was unchanged by
exercise at 35 and 65%
O2 max but increased
significantly at 1 and 10 min of 90%
O2 max. Free glucose
increased only at 10 min at 90%
O2 max.
|
Muscle acetyl-CoA was unchanged during exercise at 35%
O2 max but increased
after 10 min at 65% and 1 and 10 min at 90% (Fig.
3A). At
10 min, 90% was also higher than at 65%. Acetylcarnitine generally
followed the same pattern as acetyl-CoA (Fig.
3B).
|
Free ADP, AMP, and Pi.
Resting free ADP contents were not different between trials (89.7 ± 8.7 to 105.8 ± 15.2 µmol/kg dry muscle) and were unchanged at any
time during exercise at 35%
O2 max (Fig.
4A). At
65%, free ADP was elevated at 10 min. At 90%, free ADP at both 1 and 10 min was higher than rest and 35%, whereas the 10-min value was also
higher than 65%. Free AMP contents were not different at rest and did
not change after exercise at both 35 and 65% (Fig. 4B). At 90%, free AMP was greater
than both 35 and 65% at 1 and 10 min. Free AMP was also greater at 10 min of 90% than at 1 min. Free Pi
accumulation during exercise at 65%
O2 max was greater than
at 35% at both time points (Table 1). At 90%
O2 max, free Pi contents were greater than at
35 and 65% at both time points, and the 10-min value was higher than
at 1 min.
|
| |
DISCUSSION |
|---|
|
|
|---|
This study investigated the control of skeletal muscle glycogen metabolism at increasing exercise power outputs by examining the regulation of two key enzymes (glycogen phosphorylase and PDH). The primary findings of the study were that glycogen phosphorylase transformation is always well in excess of glycogenolytic flux, whereas PDH transformation is a good reflection of CHO flux into the mitochondria. Our data suggest that, although exercise induces transformation of glycogen phosphorylase, the magnitude of transformation is always sufficient for the required flux and is independent of aerobic power output. Posttransformational regulators linked to the power output (demand for ATP) determine the actual rate of glycogenolysis. Conversely, the regulators that control both the transformation of PDH to its more active form and the flux through the enzyme are related to the exercise power output.
For many years, the classical explanation of enzyme activation was that transformation of the enzyme into the more active form was synonymous with flux through the enzyme. However, for glycogen phosphorylase, the simple conversion of b to a forms alone cannot account for the glycogenolytic rate, as illustrated by epinephrine infusion and caffeine ingestion studies. In the case of epinephrine infusion at physiological levels, glycogen phosphorylase reaches nearly total conversion to the a form, yet flux through the enzyme is much lower than expected, suggesting that actual glycogenolysis is related to the energy state of the cell and not transformation (6, 9). Similarly, after caffeine ingestion, the percentage of glycogen phosphorylase in the a form is significantly increased, whereas glycogen is in fact "spared" during aerobic exercise compared with control (8, 35).
Conversely, PDH transformation has previously been shown to be more
closely matched to PDH flux under most situations. Exercise studies
have shown that the calculated flux through PDH is almost stoichiometric with the transformation of PDH to the
a form (13, 28, 29). However, one
study reported no further activation of PDH when comparing activities
at 90 vs. 60%
O2 max
while CHO oxidation and flux through PDH increased (11). The close match reported in most studies can be uncoupled under certain conditions. Subjects on a low-CHO diet showed similar PDH
a values compared with high-CHO
controls during exercise, but, due to the low muscle glycogen contents,
flux through PDH was ~50% of PDH a
during exercise in the low-CHO condition. These data suggest that
transformation and flux are not always equivalent for this enzyme (29).
Control of glycogen phosphorylase.
Several previous studies have demonstrated that the rate of
glycogenolysis, and thus flux through glycogen phosphorylase, increases
as a function of power output (10, 31, 34). Although resting glycogen
phosphorylase a was not measured in
this study, as separate biopsies would be required, it has been shown
that resting glycogen phosphorylase a
averages ~10% or less (7, 27). Therefore, in the present study,
glycogen phosphorylase transformation to the
a form increased from rest at all
power outputs (Fig. 1). However, in accordance with our hypothesis,
glycogen phosphorylase transformation during exercise did not differ
with increasing power output, despite the required increase in flux
through glycogen phosphorylase (glycogenolysis). It is important to
note, however, that the potential flux through glycogen phosphorylase,
based on the catalytic activity of the transformed enzyme (glycogen
phosphorylase a), was always well in
excess of the estimated flux through the enzyme. Potential glycogen
phosphorylase activity (i.e.,
Vmax of the more
active a form) ranged from 23.4 ± 4.8 to 41.3 ± 11.0 mmol · kg dry
muscle
1 · min
1
(Table 1), whereas the rate of glycogenolysis reached only
12.4 mmol · kg dry
muscle
1 · min
1
at 90%
O2 max and was
much less at the lower power outputs. Therefore, glycogen phosphorylase
transformation was well in excess of what was needed at all power
outputs. The disparity between the low rate of glycogen phosphorylase
flux and its potential catalytic activity is due to the fact that
glycogenolysis does not provide substrate solely for oxidative
metabolism (10). To maintain high rates of anaerobic ATP turnover
during very intense bouts of exercise, glycogenolysis must also be
capable of reaching fluxes through glycogen phosphorylase that approach
its maximum potential (i.e., ~150 mmol · kg dry
muscle
1 · min
1).
Using an isokinetic cycle ergometer at very high power outputs, Parolin
et al. (27) showed that glycogen phosphorylase transformation was
~60% within 6 s and that glycogenolytic flux approached the Vmax total of
glycogen phosphorylase.
It appears that transformation of glycogen phosphorylase by phosphorylation is obligatory to permit glycogenolysis during exercise, but the degree of transformation is not necessarily related to the actual flux through the enzyme. The transformation from the less active b to more active a form occurs with the onset of exercise, due to a stimulation of phosphorylase a kinase by Ca2+ (5, 17). A second stage of control, which serves to regulate the flux through glycogen phosphorylase, is related to the energy status of the cell. Increases in glycogen phosphorylase flux have been shown to correlate with increases in both free Pi and free AMP (glycogen phosphorylase substrate and allosteric modulator, respectively). Both free Pi and free AMP increased significantly with power output (Table 1), providing increased substrate for the glycogen phosphorylase reaction as the need for flux through the reaction increased. In support of the close relationship between glycogenolysis and free AMP, previous studies, utilizing short-term training, high-fat (Intralipid) infusion, and caffeine ingestion, have shown a blunted accumulation of free AMP during exercise when glycogen sparing occurs (7, 8, 20).
Glycogen phosphorylase a was
significantly reduced after 10 min at 90%
O2 max. This fall may
have been caused by the increasing acidosis of the muscle at this power
output and duration as the calculated muscle pH fell to 6.61 ± 0.04 (Table 2). Low pH inhibits phosphorylase
b kinase and would lower
transformation into the a form (5). It
has been shown that glycogen phosphorylase transformation is inhibited
with repeated intense bouts of exercise when muscle pH approached 6.4 (27).
PDH regulation. Transformation of PDH is regulated by the balance between PDH kinase (deactivating) and PDH phosphatase (activating; see Refs. 26 and 38). PDH kinase is believed to be inhibited by pyruvate and high CoASH/acetyl-CoA or NAD-to-NADH ratios and stimulated by high ATP/ADP (14, 23, 38). Conversely, PDH phosphatase is stimulated by Ca2+ (1).
In contrast to glycogen phosphorylase, PDH transformation rose as a
function of increasing power output in the present study. Constantin-Teodosiu et al. (11) had subjects cycle at 30, 60, and 90%
O2 max consecutively
and reported increases in PDH transformation at 30 and 60%
O2 max. There was no
further increase at 90%
O2 max, as
was observed in the present study. However, we feel that the increase
in PDH at the high power output is necessary to account for the
increased CHO oxidation that occurs when moving from 60 to 90%
O2 max. To
test whether the increase in PDH transformation was equal to the flux
through the enzyme, we estimated PDH flux by different methods,
depending on the power output. For the 35 and 65%
O2 max power outputs,
PDH flux was estimated from
O2 and RER, and an estimate
of active muscle mass. The total amount of CHO oxidized during the 10 min was calculated (21) and converted to mmol pyruvate
· kg
1 · min
1,
assuming an active muscle mass of 10 kg (16, 29). This resulted in
calculated PDH fluxes of 1.17 ± 0.19 and 2.20 ± 0.27 mmol · kg wet
muscle
1 · min
1
for 35 and 65%
O2 max,
respectively, compared with measured PDH
a activities of 1.53 and 2.98 mmol · kg wet
muscle
1 · min
1
for the two power outputs. At 90%
O2 max, total
glycogenolysis was determined as the difference between resting and
10-min glycogen measurements. The PDH flux was estimated as (total
glycogenolysis + glucose uptake)
(muscle lactate and glycolytic
intermediate accumulation + blood lactate efflux), assuming an active
muscle mass of 10 kg. Glucose uptake was estimated based on the data of
Katz et al. (25). Lactate efflux was estimated, assuming that 20% of
the total lactate produced left the muscle. This calculation resulted
in a PDH flux of 3.45 ± 0.59 mmol · kg wet
muscle
1 · min
1.
Measured PDH a activity at this power
output averaged 3.89 mmol · kg wet
muscle
1 · min
1
between 1 and 10 min.
When the activity of PDH at different power outputs is compared with the estimated PDH flux (Fig. 5), it is apparent that PDH transformation is closely matched to the flux through the enzyme, as suggested previously (1, 28, 29). The probable stimuli for the increase in PDH a are the increases in Ca2+ concentration and pyruvate concentration observed with increasing power output (1, 11, 28, 32). Ca2+ increases during muscle contraction would activate PDH phosphatase and stimulate PDH transformation to the active form. Likewise, because pyruvate is both an inhibitor of PDH kinase, and a substrate for PDH, an increase in pyruvate would increase the transformation of PDH and flux through the PDH reaction.
|
The rise in acetyl-CoA and acetylcarnitine with increasing power output is similar to that shown by others (11, 32). However, despite its proposed inhibitory effects, the rise in acetyl-CoA levels did not suppress the increase in PDH a with increasing power output. It is very likely that other activating factors override the acetyl-CoA inhibition that may occur in a resting situation (28). To prevent the rise in acetyl-CoA from trapping all of the available free CoA, thereby slowing PDH flux and several other reactions, the acetyl groups are transferred to carnitine, increasing the acetylcarnitine concentration and buffering the removal of free CoA from the system (28, 32).
The muscle ATP-to-ADP ratio decreased with increasing power output, as ATP did not change across power outputs (Table 2), but free ADP rose markedly with increased power output (Fig. 4A). The fall in the ATP-to-ADP ratio would be expected to increase the transformation of PDH to the active form due to inhibition of PDH kinase. The relationship between the NADH-to-NAD ratio and PDH transformation is difficult to quantify due to the difficulty in measuring the mitochondrial redox state during exercise. One study, using the direct, bioluminescent measurement of NADH, demonstrated that PDH transformation was independent of mitochondrial redox (13). Conversely, using the glutamate dehydrogenase equilibrium method to estimate NADH/NAD, a second group found that the fall in NADH was consistent with stimulation of PDH transformation (28). Until a proven method of measuring mitochondrial redox during exercise is established, this relationship will remain unclear.
Coordinate regulation of glycogen phosphorylase and
PDH. Increases in exercise power output require
increased rates of ATP degradation and increased rates of ATP provision
from oxidative metabolism. As the power output increases, a greater
mismatch between energy demand and provision occurs at the onset of
exercise. The present data demonstrate that muscle cells can provide
the required ATP with very few homeostatic changes from rest at 35%
O2 max. However, at 65 and 90%, a greater mismatch between ATP demand and provision is
reflected by the increased breakdown of PCr and the accumulation of
free ADP, AMP, and Pi after 1 min of exercise (Table 2). This fall in the energy state of the cell stimulates tricarboxylic acid (TCA) cycle activity,
mitochondrial respiration, and the enzymes of glycogen metabolism
(glycogen phosphorylase and PDH). Likewise, increases in cellular free
Ca2+ that occur with increasing
power outputs increase the transformation of both glycogen
phosphorylase (17) and PDH (1) to their more active forms, especially
at the onset of exercise.
The results of the present study suggest that the increased concentrations of free AMP and Pi exert a positive feedback effect on the flux through glycogen phosphorylase a to increase glycogen breakdown and pyruvate concentration. The initial rise in pyruvate during the transition to steady-state exercise "feeds forward" on PDH to increase PDH a and allows for the increased flux required to support oxidative metabolism. Therefore, the rates of pyruvate delivery and oxidation can be adjusted to maintain oxidative ATP production as power output increases, but at the cost of a reduced energy state of the cell.
One consequence of the increased pyruvate required to stimulate PDH is
an increased accumulation of lactate as power output increases. Because
the equilibrium enzyme lactate dehydrogenase favors the production of
lactate, a small rise in pyruvate causes a marked rise in lactate. At
90%
O2 max, PDH is
fully transformed and increases in glycolytic flux, or pyruvate cannot
be oxidized through increased PDH flux, resulting in a greater lactate
accumulation. However, it is somewhat unclear why lactate accumulates
at 65%
O2 max, since
PDH is not fully transformed and could potentially support greater
flux. It would be interesting to examine whether increased PDH
transformation from dichloroacetate (DCA) infusion would result in
greater PDH flux (and lower lactate) at this power output. DCA has been
shown to increase PDH a and
subsequently improve contractile function in ischemic canine muscle
(36, 37). Given that subjects are using almost exclusively muscle glycogen at 90%
O2 max, PDH flux (and
acetyl-CoA formation) would set the rate of TCA cycle flux (24) and
thus the rate of NADH production for oxidation by the electron
transport chain. Timmons et al. (36) hypothesized that TCA cycle flux
could be limited by substrate (acetyl-CoA) availability at the start of exercise. By increasing PDH a
transformation at rest, they were able to provide more acetyl-CoA from
acetylcarnitine at the transition from rest and subsequently increase
the initial rate of oxidative metabolism.
In summary, from this investigation it appears that several signals act to coordinate glycogen utilization over a wide range of aerobic power outputs. First, as the intensity of contractions increases, the amount of cellular free Ca2+ increases, causing transformation of both glycogen phosphorylase and PDH. Second, an increasing fall in the cellular energy state occurs with increasing power output. This fall in energy state fine tunes the rate of glycogenolysis through substrate (Pi) and allosteric (free AMP) control. Third, pyruvate production from glycogenolysis feeds forward to further regulate the transformation of and flux through PDH. In conclusion, the present data demonstrate mechanistically how a rise in CHO use could occur based on metabolic signals related to exercise intensity.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Tina Bragg and Dr. Phanelie Berthon for excellent technical assistance.
| |
FOOTNOTES |
|---|
This experiment was supported by operating grants from the Natural Sciences and Engineering Research and Medical Research Councils of Canada. R. A. Howlett was supported by a Gatorade Sports Science Institute student research award. M. L. Parolin is supported by an National Sciences and Engineering Research Council (NSERC) studentship. D. J. Dyck was supported by an NSERC postdoctoral fellowship. G. J. F. Heigenhauser is a Career Investigator of the Heart and Stroke Foundation of Ontario.
Address for reprint requests: R. A. Howlett, Dept. of Human Biology and Nutritional Sciences, Univ. of Guelph, Guelph, ON, Canada N1G 2W1.
Received 22 December 1997; accepted in final form 1 April 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ashour, B.,
and
G. Hansford.
Effect of fatty acids and ketones on the activity of pyruvate dehydrogenase in skeletal-muscle mitochondria.
Biochem. J.
214:
725-736,
1983[Medline].
2.
Bergmeyer, H. U.
Methods of Enzymatic Analysis. New York: Academic, 1974.
3.
Bergstrom, J.
Percutaneous needle biopsy of skeletal muscle in physiological and clinical research.
Scand. J. Clin. Lab. Invest.
35:
609-616,
1975[Medline].
4.
Cederblad, G.,
J. I. Carlin,
D. Constantin-Teodosiu,
P. Harper,
and
E. Hultman.
Radioisotopic assays of CoASH and carnitine and their acetylated forms in human skeletal muscle.
Anal. Biochem.
185:
274-278,
1990[Medline].
5.
Chasiotis, D.,
K. Sahlin,
and
E. Hultman.
Regulation of glycogenolysis in human muscle at rest and during exercise.
J. Appl. Physiol.
53:
708-715,
1982
6.
Chasiotis, D.,
K. Sahlin,
and
E. Hultman.
Regulation of glycogenolysis in human muscle in response to epinephrine infusion.
J. Appl. Physiol.
54:
45-50,
1983
7.
Chesley, A.,
G. J. F. Heigenhauser,
and
L. L. Spriet.
Regulation of muscle glycogen phosphorylase activity following short-term endurance training.
Am. J. Physiol.
270 (Endocrinol. Metab. 33):
E328-E335,
1996
8.
Chesley, A.,
R. A. Howlett,
G. J. F. Heigenhauser,
E. Hultman,
and
L. L. Spriet.
Regulation of muscle glycogenolytic flux during intense aerobic exercise following caffeine ingestion.
Am. J. Physiol.
275 (Regulatory Integrative Comp. Physiol. 44):
R596-R603,
1998
9.
Chesley, A.,
E. Hultman,
and
L. L. Spriet.
Effects of epinephrine infusion on muscle glycogenolysis during intense aerobic exercise.
Am. J. Physiol.
268 (Endocrinol. Metab. 31):
E127-E134,
1995
10.
Connett, R. J.,
and
K. Sahlin.
Control of glycolysis and glycogen metabolism.
In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda, MD: Am. Physiol. Soc., 1996, sect. 12, chapt. 19, p. 870-911.
11.
Constantin-Teodosiu, D.,
J. I. Carlin,
G. Cederblad,
R. C. Harris,
and
E. Hultman.
Acetyl group accumulation and pyruvate dehydrogenase activity in human muscle during incremental exercise.
Acta Physiol. Scand.
143:
367-372,
1991[Medline].
12.
Constantin-Teodosiu, D.,
G. Cederblad,
and
E. Hultman.
A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue.
Anal. Biochem.
198:
347-351,
1991[Medline].
13.
Constantin-Teodosiu, D.,
G. Cederblad,
and
E. Hultman.
PDC activity and acetyl group accumulation in skeletal muscle during isometric contraction.
J. Appl. Physiol.
74:
1712-1718,
1992
14.
Cooper, R. H.,
P. J. Randle,
and
R. M. Denton.
Stimulation of phosphorylation and inactivation of pyruvate dehydrogenase by physiological inhibitors of the pyruvate dehydrogenase reaction.
Nature
257:
808-809,
1975[Medline].
15.
Cori, G. T.
The effect of stimulation and recovery on the phosphorylase a content of muscle.
J. Biol. Chem.
151:
31-38,
1945
16.
Coyle, E. F.,
A. R. Coggan,
M. K. Hopper,
and
T. J. Walters.
Determinants of endurance in well-trained cyclists.
J. Appl. Physiol.
64:
2622-2630,
1988
17.
Danforth, W. H.,
and
E. Helmrich.
The conversion of phosphorylase b to a in frog sartorious muscle.
J. Biol. Chem.
239:
3133-3138,
1964
18.
Dill, D. B.
The economy of muscular exercise.
Physiol. Rev.
16:
263-291,
1936
19.
Dudley, G. A.,
P. C. Tullson,
and
R. L. Terjung.
Influence of mitochondrial content on the sensitivity of respiratory control.
J. Biol. Chem.
262:
9109-9114,
1987
20.
Dyck, D. J.,
S. J. Peters,
P. S. Wendling,
A. Chesley,
E. Hultman,
and
L. L. Spriet.
Regulation of muscle glycogen phosphorylase activity during intense aerobic cycling with elevated FFA.
Am. J. Physiol.
270 (Endocrinol. Metab. 33):
E116-E125,
1996
21.
Frayn, K. N.
Calculation of substrate oxidation rates in vivo from gaseous exchange.
J. Appl. Physiol.
55:
628-634,
1983
22.
Harris, R. C.,
E. Hultman,
and
L. O. Nordesjo.
Glycogen, glycolytic intermediates and high-energy phosphates determined in muscle biopsy samples of musculus quadriceps femoris of man at rest.
Scand. J. Clin. Lab. Invest.
33:
109-119,
1974[Medline].
23.
Hennig, G.,
G. Loffler,
and
O. H. Weiland.
Active and inactive forms of pyruvate dehydrogenase in skeletal muscle as related to the metabolic and functional state of the muscle cell.
FEBS Lett.
59:
142-145,
1975[Medline].
24.
Hultman, E.
Pyruvate dehydrogenase as a regulator of substrate utilization in skeletal muscle.
In: Biochemistry of Exercise IX, edited by R. J. Maughn,
and S. M. Shirreffs. Champaign, IL: Human Kinetics, 1996.
25.
Katz, A.,
S. Broberg,
K. Sahlin,
and
J. Wahren.
Leg glucose uptake during maximal dynamic exercise in humans.
Am. J. Physiol.
251 (Endocrinol. Metab. 14):
E65-E70,
1986
26.
Linn, T. C.,
F. H. Pettit,
F. Hucho,
and
L. J. Reed.
-Keto acid dehydrogenase complexes. XI. Comparative studies of regulatory properties of the pyruvate dehydrogenase complexes from kidney, heart, and liver mitochondria.
Proc. Natl. Acad. Sci. USA
64:
227-234,
1969
27.
Parolin, M.,
A. Chesley,
M. Matsos,
L. L. Spriet,
M. Hollidge-Horvat,
N. L. Jones,
and
G. J. F. Heigenhauser.
Activation rate of glycogen phosphorylase and pyruvate dehydrogenase in human skeletal muscle during intense exercise (Abstract).
Med. Sci. Sports Exerc.
28:
S99,
1996.
28.
Putman, C. T.,
N. L. Jones,
L. C. Lands,
T. M. Bragg,
M. G. Hollidge-Horvat,
and
G. J. F. Heigenhauser.
Skeletal muscle pyruvate dehydrogenase activity during maximal exercise in humans.
Am. J. Physiol.
269 (Endocrinol. Metab. 32):
E458-E468,
1995
29.
Putman, C. T.,
L. L. Spriet,
E. Hultman,
M. I. Lindinger,
L. C. Lands,
R. S. McKelvie,
G. Cederblad,
N. L. Jones,
and
G. J. F. Heigenhauser.
Pyruvate dehydrogenase activity and acetyl group accumulation during exercise after different diets.
Am. J. Physiol.
265 (Endocrinol. Metab. 28):
E752-E760,
1993
30.
Ren, J. M.,
and
E. Hultman.
Regulation of phosphorylase a activity in human skeletal muscle.
J. Appl. Physiol.
69:
919-923,
1990
31.
Romijn, J. A.,
E. F. Coyle,
L. S. Sidossis,
A. Gastaldelli,
J. F. Horowitz,
E. Endert,
and
R. R. Wolfe.
Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration.
Am. J. Physiol.
265 (Endocrinol. Metab. 28):
E380-E391,
1993
32.
Sahlin, K.
Muscle carnitine metabolism during incremental dynamic exercise in humans.
Acta Physiol. Scand.
138:
259-262,
1990[Medline].
33.
Sahlin, K.,
R. C. Harris,
B. Nylind,
and
E. Hultman.
Lactate content and pH in muscle samples obtained after dynamic exercise.
Pflügers Arch.
367:
143-149,
1976[Medline].
34.
Saltin, B.,
and
J. Karlsson.
Muscle glycogen utilization during work at different intensities.
In: Muscle Metabolism During Exercise, edited by B. Pernow,
and B. Saltin. New York: Plenum, 1971.
35.
Spriet, L. L.,
D. A. MacLean,
D. J. Dyck,
E. Hultman,
G. Cederblad,
and
T. E. Graham.
Caffeine ingestion and muscle metabolism during prolonged exercise in humans.
Am. J. Physiol.
262 (Endocrinol. Metab. 25):
E891-E898,
1992
36.
Timmons, J. A.,
S. M. Poucher,
D. Constantin-Teodosiu,
I. A. Macdonald,
and
P. L. Greenhaff.
Metabolic responses from rest to steady state determine contractile function in ischemic skeletal muscle.
Am. J. Physiol.
273 (Endocrinol. Metab. 36):
E233-E238,
1997
37.
Timmons, J. A.,
S. M. Poucher,
D. Constantin-Teodosiu,
V. Worrall,
I. A. Macdonald,
and
P. L. Greenhaff.
Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia.
J. Clin. Invest.
97:
879-883,
1996[Medline].
38.
Weiland, O. H.
The mammalian pyruvate dehydrogenase complex: structure and regulation.
Rev. Physiol. Biochem. Pharmacol.
96:
124-170,
1983.
39.
Young, D. A.,
H. Wallberg-Henriksson,
J. Cranshaw,
M. Chen,
and
J. O. Holloszy.
Effect of catecholamines on glucose uptake and glycogenolysis in rat skeletal muscle.
Am. J. Physiol.
248 (Cell Physiol. 17):
C406-C409,
1985
This article has been cited by other articles:
![]() |
C. Rantzau, M. Christopher, and F. P. Alford Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism J Appl Physiol, February 1, 2008; 104(2): 363 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Bradley, G. J. F. Heigenhauser, B. D. Roy, E. M. Staples, J. G. Inglis, P. J. LeBlanc, and S. J. Peters The acute effects of differential dietary fatty acids on human skeletal muscle pyruvate dehydrogenase activity J Appl Physiol, January 1, 2008; 104(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Gurd, S. J. Peters, G. J. F. Heigenhauser, P. J. LeBlanc, T. J. Doherty, D. H. Paterson, and J. M. Kowalchuk Prior heavy exercise elevates pyruvate dehydrogenase activity and speeds O2 uptake kinetics during subsequent moderate-intensity exercise in healthy young adults J. Physiol., December 15, 2006; 577(3): 985 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Talanian, R. J. Tunstall, M. J. Watt, M. Duong, C. G. R. Perry, G. R. Steinberg, B. E. Kemp, G. J. F. Heigenhauser, and L. L. Spriet Adrenergic regulation of HSL serine phosphorylation and activity in human skeletal muscle during the onset of exercise Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R1094 - R1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mourtzakis, B. Saltin, T. Graham, and H. Pilegaard Carbohydrate metabolism during prolonged exercise and recovery: interactions between pyruvate dehydrogenase, fatty acids, and amino acids J Appl Physiol, June 1, 2006; 100(6): 1822 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stellingwerff, P. J. LeBlanc, M. G. Hollidge, G. J. F. Heigenhauser, and L. L. Spriet Hyperoxia decreases muscle glycogenolysis, lactate production, and lactate efflux during steady-state exercise Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1180 - E1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Roberts, S. J. G. Loxham, S. M. Poucher, D. Constantin-Teodosiu, and P. L. Greenhaff Acetyl-CoA provision and the acetyl group deficit at the onset of contraction in ischemic canine skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E327 - E334. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stellingwerff, L. Glazier, M. J. Watt, P. J. LeBlanc, G. J. F. Heigenhauser, and L. L. Spriet Effects of hyperoxia on skeletal muscle carbohydrate metabolism during transient and steady-state exercise J Appl Physiol, January 1, 2005; 98(1): 250 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. LeBlanc, K. R. Howarth, M. J. Gibala, and G. J. F. Heigenhauser Effects of 7 wk of endurance training on human skeletal muscle metabolism during submaximal exercise J Appl Physiol, December 1, 2004; 97(6): 2148 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Watt, G. J. F. Heigenhauser, P. J. LeBlanc, J. G. Inglis, L. L. Spriet, and S. J. Peters Rapid upregulation of pyruvate dehydrogenase kinase activity in human skeletal muscle during prolonged exercise J Appl Physiol, October 1, 2004; 97(4): 1261 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bezaire, G. J. F. Heigenhauser, and L. L. Spriet Regulation of CPT I activity in intermyofibrillar and subsarcolemmal mitochondria from human and rat skeletal muscle Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E85 - E91. [Abstract] [Full Text] |
||||
![]() |
H. B. Rossiter, S. A. Ward, F. A. Howe, D. M. Wood, J. M. Kowalchuk, J. R. Griffiths, and B. J. Whipp Effects of dichloroacetate on VO2 and intramuscular 31P metabolite kinetics during high-intensity exercise in humans J Appl Physiol, September 1, 2003; 95(3): 1105 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Longnus, R. B. Wambolt, H. L. Parsons, R. W. Brownsey, and M. F. Allard 5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R936 - R944. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stellingwerff, M. J. Watt, G. J. F. Heigenhauser, and L. L. Spriet Effects of reduced free fatty acid availability on skeletal muscle PDH activation during aerobic exercise Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E589 - E596. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Savasi, M. K. Evans, G. J. F. Heigenhauser, and L. L. Spriet Skeletal muscle metabolism is unaffected by DCA infusion and hyperoxia after onset of intense aerobic exercise Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E108 - E115. [Abstract] [Full Text] [P |